Ameritas Investment Partners’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $211K | Hold |
8,948
| – | – | 0.01% | 1237 |
|
|
2025
Q4 | $260K | Hold |
8,948
| – | – | 0.01% | 1107 |
|
|
2025
Q3 | $169K | Sell |
8,948
-2,297
| -20% | -$36.2K | 0.01% | 1330 |
|
|
2025
Q2 | $158K | Hold |
11,245
| – | – | 0.01% | 1454 |
|
|
2025
Q1 | $176K | Hold |
11,245
| – | – | 0.01% | 1339 |
|
|
2024
Q4 | $157K | Buy |
11,245
+837
| +8% | +$9.17K | 0.01% | 1480 |
|
|
2024
Q3 | $96.8K | Hold |
10,408
| – | – | ﹤0.01% | 1819 |
|
|
2024
Q2 | $96.8K | Buy |
10,408
+2,537
| +32% | +$22.9K | ﹤0.01% | 1749 |
|
|
2024
Q1 | $78K | Buy |
7,871
+2,800
| +55% | +$20.9K | ﹤0.01% | 1892 |
|
|
2023
Q4 | $16.4K | Hold |
5,071
| – | – | ﹤0.01% | 2674 |
|
|
2023
Q3 | $26.9K | Buy |
5,071
+825
| +19% | +$7.02K | ﹤0.01% | 2412 |
|
|
2023
Q2 | $40.5K | Buy |
4,246
+1,042
| +33% | +$11.6K | ﹤0.01% | 2167 |
|
|
2023
Q1 | $35.2K | Hold |
3,204
| – | – | ﹤0.01% | 2191 |
|
|
2022
Q4 | $52.3K | Hold |
3,204
| – | – | ﹤0.01% | 2023 |
|
|
2022
Q3 | $61K | Buy |
3,204
+577
| +22% | +$13.1K | ﹤0.01% | 1831 |
|
|
2022
Q2 | $55K | Buy |
2,627
+747
| +40% | +$15.3K | ﹤0.01% | 1926 |
|
|
2022
Q1 | $36K | Hold |
1,880
| – | – | ﹤0.01% | 2246 |
|
|
2021
Q4 | $39K | Hold |
1,880
| – | – | ﹤0.01% | 2287 |
|
|
2021
Q3 | $45K | Hold |
1,880
| – | – | ﹤0.01% | 2229 |
|
|
2021
Q2 | $51K | Hold |
1,880
| – | – | ﹤0.01% | 2162 |
|
|
2021
Q1 | $54K | Buy |
1,880
+340
| +22% | +$10.6K | ﹤0.01% | 2034 |
|
|
2020
Q4 | $43K | Hold |
1,540
| – | – | ﹤0.01% | 2070 |
|
|
2020
Q3 | $45K | Buy |
1,540
+643
| +72% | +$17.2K | ﹤0.01% | 1905 |
|
|
2020
Q2 | $27K | Hold |
897
| – | – | ﹤0.01% | 2173 |
|
|
2020
Q1 | $27K | Buy |
+897
| New | +$24.1K | ﹤0.01% | 1999 |
|
Other funds holding ARQT
SCM
FLSM
RCMNY
PCH
VCM
GGHC
